Type
. Type 1 reactions in leprosy, neuritis and steroid therapy: the impact of the human immunodeficiency virus. Trans R Soc Trop Med Hyg. 1994;88(3):315-6.
Type
. Leprosy care. The impact of multiple drug therapy. Africa health. 1994;16(4):21-4.
Type
. Leprosy and infection with the human immunodeficiency virus in Uganda; a case-control study. International journal of leprosy & other Mycobactial diseases [Internet]. 1994;62(4):521-6. Available from: http://ila.ilsl.br/pdfs/v62n4a03.pdf
Type
. Is leprosy blindness avoidable? The effect of disease type, duration, and treatment on eye damage from leprosy in Uganda. British journal of ophthalmology [Internet]. 1995;79(3):250-6. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC505073/pdf/brjopthal00015-0052.pdf
Type
. Prophylaxis--scope and limitations. Leprosy review [Internet]. 2000;71 Suppl:S16-9; discussion S19-20. Available from: http://leprev.ilsl.br/pdfs/2000/v71s1/pdf/v71s1a03.pdf
Type
. The worldwide importance of bed nets. Pediatric annals. 2007;36(12):764-5.
Type
. Potential role of dermatologists and dermatological services in developing and sustaining the leprosy control referral system in resource constrained settings. Leprosy review [Internet]. 2007;78(1):34-7. Available from: https://leprosyreview.org/article/78/1/03-437
Type
. Life-threatening mycobacteria infection. Clinics in dermatology. 2005;23(3):254-7.
Type
. Mapping genetic variants in the CFH gene for association with leprosy in Han Chinese. Genes & immunity. 2014;.
Type
. [Psychosocial, economic and physical status of former leprosy patients in Uganda]. Gesundheitswesen. 2000;62(6):342-6.